Job Description: Join J.P. Morgan's dynamic team as a Vice President in FICC Market Structure & Liquidity Strategy... drive J.P. Morgan's initiatives across the Macro and Spread businesses in APAC. You will develop client relationships...
market team of J.P. Morgan Private Bank, you are responsible for advising families on building, preserving and managing... Strong knowledge of relevant financial markets and instruments About Us: J.P. Morgan is a global leader in financial services...
Our client is Your creative solutions supplier. Job Description Flexible working options Excellent career development opportunities Work alongside & learn from best in class talent The Job You will be responsible for : Writing...
to permanent employment. About Us: J.P. Morgan is a global leader in financial services, providing strategic advice and products.... Visit our for more information about requesting an accommodation. About the Team: J.P. Morgan's Commercial & Investment...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »